TOKYO, Dec 13, 2022 - (JCN Newswire via SEAPRWire.com) - Hitachi High-Tech Corporation announced today the launch of the LS9600, a new system for detecting particles and defects on non-patterned wafer surfaces. It features a new high-output, short-wavelength laser that improves throughput at the sensitivity levels required for the mass production of cutting-edge semiconductor devices by approx. 2.6 times compared to our previous generation systems. By introducing this product, Hitachi High-Tech will continue to help to improve yields and reduce inspection costs associated with customers' mass production of semiconductor devices.Wafer Surface Inspection System LS9600Development BackgroundNon-patterned wafer inspection systems are used for applications such as controlling the condition (cleanliness) of non-patterned wafers to manage particles and defects in semiconductor device manufacturing equipment. Due to the shrinking of semiconductor devices, the defects of interest (DOIs), which impact yield during the manufacturing process, have also become smaller in size. As a result, there is a growing need for high-sensitivity inspection that can detect DOIs of 20 nm and smaller across the entire surface of non-patterned wafers. In addition to high-sensitivity inspection to improve yield, there is also a strong demand for high throughput, which leads to lower inspection costs.Key New TechnologiesThis system achieves both high sensitivity and high throughput by implementing the following new technologies.1. High-Output, Short-Wavelength LaserThe deep-ultraviolet laser has a higher output and shorter wavelength than legacy systems, which increases the amount of light scattered by microscopic defects, thereby achieving a higher degree of sensitivity.2. New Optical Detection SystemThe new optical detection system features a larger surface area to capture light scattered by DOIs compared to the legacy systems. In addition, its newly developed high-sensitivity sensor has improved the detection rate of weak scattered light by around 20%.3. New Data Processing SystemImproved scattered light data-processing algorithms deliver higher sensitivity, together with higher throughput due to high-speed, real-time data processing.By using this product, as well as our wafer optical inspection systems, and electron beam-based products such as a traditional CD-SEM(1) and DR-SEM(2), Hitachi High-Tech is working to meet customers' various needs in processing, measurement, and inspection throughout the semiconductor manufacturing process. We will continue to provide innovative and digitally enhanced solutions to our products for the upcoming technology challenges, and create new value together with our customers, as well as contributing to cutting-edge manufacturing.(1) CD-SEM (Critical Dimension-Scanning Electron Microscope): An equipment for measuring the microscopic circuit patterns on semiconductor wafers. Used for inspections on semiconductor devices development and production lines, these systems are essential for yield management.(2) DR-SEM (Defect Review-Scanning Electron Microscope): An equipment for reviewing the microscopic circuit patterns and defects on semiconductor wafers. Used for inspections on semiconductor devices development and production lines, these systems are essential for yield management.About Hitachi High-TechHitachi High-Tech, headquartered in Tokyo, Japan, is engaged in activities in a broad range of fields, including manufacture and sales of clinical analyzers, biotechnology products, and analytical instruments, semiconductor manufacturing equipment and analysis equipment. and providing high value-added solutions in fields of social & industrial infrastructures and mobility, etc. The company's consolidated revenues for FY 2021 were approx. JPY 576.8 billion [USD 5.1 billion]. For further information, visit www.hitachi-hightech.com/global/Contact:Yuuki MinataniBusiness Planning Dept., Metrology Systems Div.,Nano-Technology Solution Business Group, Hitachi High-Tech CorporationE-mail: yuki.minatani.dc@hitachi-hightech.com Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More and more screens play a quite big role in many aspects of our lives and link to the outside. Half a century ago, the first liquid crystal display was invented a turning point in the application of liquid crystal materials. With people’s pursuit of display color and display practicability, the display device market has undergone earth-shaking changes in the last century. Screen has replaced printing technology as the main way of knowledge and information dissemination. Especially in recent years, with the rapid development of communication technology and people’s pursuit of color and display practicability of display devices, the display devices are forced to develop in the direction of multi-function and digitization. Jlink recently released new gaming monitors, and they are offering some sweet deals on them right now and these discounts are available on a limited-time basis. Focusing on display and link technology, Jlink firmly believes that only the joy in the heart is the real joy. Starting from the joyful experience and convenient link of consumers, Jlink continues to innovate in viewing experience, adaptive flexibility, and rich connectivity always with the same goal: link people to a joyful future. Adopting advanced technology, Jlink Computer Monitors and Gaming Monitors meet a variety of usage needs and broaden your horizons. It recently delivered a decent variety of HD gaming monitors at relatively affordable prices with discounts due to new launches. It has an adjustable height stand and can pivot and tilt to reach the best angle possible in any setup. With crisp 1440P resolution and 16:9 aspect ratio, gamers could view more contents clearly and sweep to victory. Jlink offers a standard, 27-inch 1080P monitor. The monitor features an ultra-slim screen with HDMI and DisplayPort inputs. It features a 165Hz refresh rate and 1ms response time. This 1080p monitor features a 165Hz refresh rate, 1ms response times, HDR, and anti-glare tech. It comes with Freesync and G-sync baked in, and it even filters out blue light to help with eye protection. All in all, the monitor adopts VA panel to present vivid colors and well maintain their authenticity, offering good picture, excellent color saturation, and an overall great experience. Next up, the gaming monitor is designed with adjustable tilt angle so that gamers can choose their most proper screen position and battle comfortably. It can also connect to the HDMI port, USB port and 2 Display port connecting with computers and other electronics. It is ready to use right out of the box as all cables and accessories are included in the package. Jlink is offering a special limited-time basis launch discount worth via Amazon Clip Coupon (URL: https://www.amazon.com/dp/B0B586WC5T?th=1). Grab the offer right now and enjoy high quality computing experience. The monitor can be used for a wide range of scenarios such as online learning, WFH, gaming, entertainment and much more. Media Contact Company Name: Jlink Contact Person: Trinity Email: trinity@gotvoom.com Phone: +86 18665879862 Country: United States Website: https://jlink-global.com/
Nasdaq-listed technology innovator, Qualcomm, will form a tripartite alliance with Bkav and Excelpoint to create a complete ecosystem for AIoT applicationsAIoT is the next transformational technology trend via the combination of two powerful technologies, artificial intelligence (AI) technologies and the internet of things (IoT) infrastructure According to a report by ResearchAndMarkets.com, the global AIoT market will reach US$83.6 billion by 2027, growing at 39.1% compounded growth rate per annumEnabling New Business Opportunities and Innovations within the AIoT Technology SpectrumSingapore, Oct 19, 2022 - (ACN Newswire via SEAPRWire.com) - Singapore-based Excelpoint Systems (Pte) Ltd. ("Excelpoint"), a leading regional B-to-B business platform providing quality electronics components with integrated R&D capabilities, and Bkav Hardware Solution ("BHS"), a member of Vietnam-based Bkav Corporation ("Bkav") that is a technology group that specialises in cyber security, software, e-government, smartphone manufacturing and smart electronic devices, Smart City and AI camera, are pleased to announce the signing of a strategic collaboration to develop and commercialise an Artificial Intelligence of Things ("AIoT") platform built on Qualcomm chipsets and technology ecosystem.Mr. Nguyen Tu Quang, Chairman of Bkav Group and Mr. Albert Phuay, CEO of Excelpoint (left to right)AIoT is the combination of two powerful technologies, artificial intelligence (AI) technologies and the internet of things (IoT) infrastructure, where such AIoT devices and applications can analyse data and make decisions and act on that data without involvement by humans, enhancing efficiency and effectiveness.In the near future, it is anticipated that AIoT integration within businesses and industries (such as Smart Cities, Smart Homes, Industrial 4.0, Smart Retail Chains, Autonomous Vehicles, among others) will ultimately lead to more sophisticated and valuable inter-business and cross-industry solutions.According to a report by ResearchAndMarkets.com, the global AIoT market will reach US$83.6 billion by 2027, growing at 39.1% compounded growth rate per annum.Tripartite alliance between Qualcomm, Excelpoint and Bkav to develop and commericalise AIoT platform that facilitates the creation of new AIoT devices and innovationsWhile there is increasing proliferation of AIoT devices and applications, there are limited commercially-ready AIoT platforms and development kits as there are not many technology companies that can produce AIoT devices and applications across this specialised technological value chain, from hardware to software development.With the tripartite alliance between Qualcomm, Excelpoint, and Bkav to create a complete ecosystem for AIoT applications, it can enable businesses and communities to seamlessly adopt and integrate AIoT technology with optimal costs and time efficiency, thereby creating new business opportunities and innovations within the AIoT technology spectrum.Under the alliance, Qualcomm will provide its chipsets, while Excelpoint will pursue the business development opportunities related to AIoT through its strong distribution networks. Levergaing on its technological strengths and manufacturing capabilities, Bkav shall undertake the role of a supplier of hardware, AIoT and AI platforms, such as AI Camera, AI Box, Edge Computing Servers, AIoT SoM, KIT, etc.Mr. Nguyen Tu Quang, Chairman of Bkav Group, said: "With the strategic collaboration of technology-leading companies such as Qualcomm and Excelpoint, Bkav will use our competitive strengths to develop the core foundation for the AIoT ecosystem, so as to accelerate the revolution of Industry 4.0 and contribute positively to an increasingly-connected world driven by technology."Mr. Albert Phuay, CEO of Excelpoint, added, "We are very honoured to be a part of this strategic collaboration, value-adding to the future of AIoT. Excelpoint started our AIoT journey early, building up strong networks and knowledge within this emerging field. In Singapore, we have set up various development teams to unlock the technology and business opportunities of AIoT, such as Smart Parking, Electric and Automated Vehicles, Smart Surveillance and Security, among others. With our continual dedication and commitment in the AIoT field, we are confident that our collaboration with strong partners in Qualcomm and Bkav will be able to harness emerging opportunities and contribute to the AIoT ecosystem."In May 2022, BHS was officially launched, providing services such as research, development and production of electronic products, positioning its operations as an Original Design Manufacturer ("ODM"), a business model similar to Foxconn. The strategy of BHS is to support domestic enterprises within the electronics industry, with an aim to enable hardware manufacturing companies to become market-leaders globally. BHS is a member of Bkav Corporation. For more information on Bkav, please visit https://bkav.com.vnExcelpoint is a leading regional electronics components distributor providing quality electronic components, engineering design services and supply chain management to original equipment manufacturers ("OEMs"), ODMs and electronics manufacturing services ("EMS") in the Asia Pacific region. Excelpoint is also the authorised distributor of Qualcomm in ASEAN, India, Australia and New Zealand. Established in 1987 and headquartered in Singapore, Excelpoint's business presence spans more than 10 countries across Asia Pacific with a workforce of more than 700 people from different nationalities and cultural backgrounds. For more information on Excelpoint, please visit www.excelpoint.comFor any media enquiries, please contact:Bà Đỗ Thị Thu Hằng - Giám đốc Truyền thông BkavMobile: 84 - 983. 14 33 21Email: HangDTT@bkav.comMs Phuay Li Ying Head, Corporate Development Direct: +65 6210 6649 Mobile: +65 9688 8898Email: phuay.li.ying@excelpoint.com.sg Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
TOKYO, Jun 3, 2022 - (JCN Newswire via SEAPRWire.com) - Hitachi High-Tech Corporation announced the launch of the Hitachi Dark Field Wafer Defect Inspection System DI2800, a critical component in any semiconductor manufacturer's metrology capabilities. The DI2800 is a high-speed metrology system designed to identify defects and particles on patterned wafers up to 8 inches (200 mm) in diameter. With its high throughput and performance, the DI2800 can help ensure device reliability and safety, particularly for highly sensitive applications such as Internet of Things (IoT) and automotive fields where 100% inspection is required.Hitachi Dark Field Wafer Defect Inspection System DI2800Development BackgroundWith the rise of next generation communication networks (5G) and accelerated adoption of electric vehicles in recent years there has been an increase in demand for semiconductor devices in the IoT and automotive fields where reliability and safety are paramount. In conventional semiconductor device manufacturing, spot-check inspections are performed for the purposes of process management and yield improvement. However, for semiconductor devices used in the IoT and automotive fields, 100% inspection must be carried out to help identify defective products during manufacturing to ensure high reliability and safety. To serve these fields a wafer defect inspection system must have the ability to perform 100% inspection with high sensitivity at high speed.Key FeaturesHitachi High-Tech has developed Dark Field Wafer Defect Inspection System DI2800 to respond to these market needs. This product uses scattering-intensity simulation technology to optimize the illumination and detection optics, enabling highly sensitive inspection of patterned-wafer defects developed during the manufacturing process. It has a detection sensitivity of 0.1-micron standard particle size on mirrored wafers. This performance is even possible on devices as small as 0.3-mm square, which has previously proved challenging due to sensitivity and data processing limitations. With a highly optimized inspection sequence, the DI2800 is capable of throughputs of over 40 200-mm wafers per hour.Future InitiativesHitachi High-Tech will provide this product to customers in combination with the Advanced CD Measurement SEM CS4800 and 3D SEM CT1000, which are already on the market, meeting the diverse metrology needs mass production of semiconductor devices for the IoT and automotive fields. Going forward, Hitachi is committed to product improvement by leveraging data collected from all three product lines to offer new data-based, value-added solutions, contributing to the improved reliability and safety of semiconductor devices in these fields.Hitachi High-Tech is working to meet customers' needs in metrology and inspection for the R&D and mass production of semiconductor devices by supplying electron beam-based products such as traditional CD-SEM and wafer inspection systems based on optical technologies. Hitachi High-Tech will continue to provide innovative solutions for the upcoming technology challenges. Hitachi High-Tech will contribute to the development of cutting-edge technologies by creating new social and environmental value in collaboration with its customers.About Hitachi High-TechHitachi High-Tech, headquartered in Tokyo, Japan, is engaged in activities in a broad range of fields, including manufacture and sales of clinical analyzers, biotechnology products, and analytical instruments, semiconductor manufacturing equipment and analysis equipment. and providing high value-added solutions in fields of social & industrial infrastructures and mobility, etc. The company's consolidated revenues for FY 2021 were approx. JPY 576.8 billion [USD 5.1 billion]. For further information, visit http://www.hitachi-hightech.com/global/ Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
KUALA LUMPUR, Mar 31, 2022 - (ACN Newswire via SEAPRWire.com) - Amazfit, a premium smart wearable hardware brand owned by Zepp Health Corporation ("Zepp Health"), is going to "Up Your Game" by harnessing the power of technology and science to free more people to live their passions and express their active spirits with its series of smart hardware designed for a healthy and sporting lifestyle.Amazfit Bip U Pro 1Amazfit GTS 2 Mini 2Amazfit T-rex pro 2Powered by the Zepp operating system, Amazfit connects smart devices, big data as well as sports and health management service to provide multiple personalised wearable and user experiences. Its smart devices are catered for daily or outdoor use related to health and sports, including true wireless stereo sports earbuds, smart treadmills, smart body composition scales and sports gear.Jacob Jin, Director of Amazfit Southeast Asia, said, "Amazfit is one of the most preferred brands of young people around the world who pursue an active and positive lifestyle at the cutting edge of fashion and technology. We now have over 100 million active users of our products that include watches, bands, earbuds, fitness gear and other accessories.""We are excited to launch Amazfit special Ramadan deals in April for our smart watches, where AI engines embedded in these smart devices can monitor heartbeat, exercise modes, blood-oxygen saturation levels, sleep status and breathing while sleeping, giving a better insight on how the body performs while active or at rest."Amazfit is offering special Ramadan deals in April for its smart watches that are applicable on these specific dates: 4 April, 5 April, 18 April and 25 April 2022. Purchasers who buy the T-Rex Pro on these dates will get a free Amazfit mask, those who purchase the GTS 3 and GTR 3 series of smart watches will get free hair bands and mask while those purchasing GTR 3 Pro will get free hair band, mask and bottle. Gifts are available while stocks last.The T-Rex Pro is designed for those who pursue an active outdoor lifestyle as it supports four Global Navigation Satellite Systems, 10 ATM water-resistance, a blood-oxygen saturation measurement system, a weather tracker, a sunrise and sunset monitor, a current moon phase display, a compass and barometric altimeter, ultra-long 18-day battery life with typical use, and over 100 different sports modes.Amazfit's other smart watch models include the Bip U Pro catered for those seeking a healthier and more active lifestyle to keep fit or stay in shape. The Bip U Pro come with 50 watch faces to suit mood and outfit or users can upload their photos for a more personalised watch face. Those wanting to stay fashionable and at the same time enjoy sports can go with the GTS 2 mini smart watch with its ultra-slim and light design. It also comes with over 60 built-in sports modes for a complete indoor or outdoor sports experience.To know more of the Ramadan offers, please go to www.amazfit.com/en or to Amazfit's e-commerce partner platforms http://bit.ly/Amazfit-MY-SHOPEE and https://bit.ly/Amazfit-MY-Lazada.Amazfit: www.amazfit.com/en Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
TOKYO, Jan 31, 2022 - (JCN Newswire via SEAPRWire.com) - NTT DOCOMO, INC. announced today that it will begin rolling out IPv6 single-stack support for selected DOCOMO devices from February 1, thereby taking the lead in deploying IPv6 ahead of other telecom carriers in Japan, which are expected to continue operating with IPv4 addresses for the time being.Due to the growing number of IoT devices as well as the widening adoption of 5G, IPv4 addresses are now in short supply worldwide, a key factor behind DOCOMO's decision to begin deploying virtually limitless IPv6 addresses.DOCOMO is currently providing IPv4/IPv6 dual-stack support by assigning both IPv4 and IPv6 addresses to its devices. The shift to IPv6 single-stack support was realized by using address conversion methods, which ensures interoperability with IPv4.Between July and December 2021, DOCOMO operated a test environment to allow global developers to confirm the interoperability of their applications and content on DOCOMO devices designated for conversion to single-stack support.Single-stack support will be provided for 31 IPv6 models initially and in principle for all DOCOMO devices/handsets to be released in fiscal 2022 beginning this April. Single-stack functionality will be applied to DOCOMO models operating on the DOCOMO mobile network in Japan. The company's existing communication network will not be impacted nor will users be required to change settings or submit applications.Going forward, DOCOMO is committed to playing a leading role in the expanding adoption of IPv6 addresses in communications infrastructure as well as contributing to the further development of 5G and IoT by meeting increasing demands for innovative communications equipment.About NTT DOCOMONTT DOCOMO, Japan's leading mobile operator with over 83 million subscriptions, is one of the world's foremost contributors to 3G, 4G and 5G mobile network technologies. Beyond core communications services, DOCOMO is challenging new frontiers in collaboration with a growing number of entities ("+d" partners), creating exciting and convenient value-added services that change the way people live and work. Under a medium-term plan toward 2020 and beyond, DOCOMO is pioneering a leading-edge 5G network to facilitate innovative services that will amaze and inspire customers beyond their expectations. https://www.nttdocomo.co.jp/english/. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
TOKYO, Sep 28, 2021 - (JCN Newswire via SEAPRWire.com) - Showa Denko K.K. (SDK; TSE:4004) concluded a long-term supply contract with Toshiba Electronic Devices & Storage Corporation (Toshiba), a Japanese electronic device manufacturer providing highly efficient SiC-power-semiconductor based power devices for the global market, to supply SiC epitaxial wafers for power semiconductors (SiC epi-wafers) for two and a half years with an optional extension clause.Toshiba has been developing and commercializing various kinds of SiC-based power devices including inverters for railcars, while adopting SiC epi-wafers manufactured by SDK as main material for SiC-based schottky barrier diode[1] (SiC SBD) and SiC-based metal-oxide-semiconductor field-effect transistor[2] (SiC MOSFET).Toshiba decided to conclude this long-term contract because the company appreciated homogeneity in properties[3] and low density of surface defects[4] of SiC epi-wafers manufactured by SDK. This long-term contract will further strengthen technical cooperation between SDK and Toshiba on improvement in performance of SiC epi-wafers. In addition, SDK expects that Toshiba's adoption of SiC epi-wafers manufactured by SDK will help SDK to expand its SiC epi-wafer business further.As the largest independent manufacturer of SiC epi-wafers (estimated by SDK), and under a motto of "Best in Class," the Showa Denko Group will continue coping with rapid expansion of the market for SiC epi-wafers and providing the market with high-performance and highly-reliable products, thereby contributing to the propagation of SiC power semiconductors which save energy with small power loss and less heat generation.[1] "Schottky barrier diode" (SBD) is a kind of diode whose structure includes semiconductor-metal junction instead of PN junction. SBDs are suitable for high-speed switching, and are widely used in switched-mode power supplies.[2] "Metal-oxide-semiconductor field effect transistor" (MOSFET) is a kind of transistor which functions fast and has precision control. Therefore, MOSFETs are widely used in switched mode power supplies for power electronics, including converters to control voltage and frequency, and inverters.[3] "Homogeneity in properties" means that homogeneity in doping of nitrogen which determines physical property of wafer has been achieved. SiC power semiconductor is produced from SiC doped with nitrogen. SiC power semiconductor for high voltage requires homogeneous doping with small amount of nitrogen.[4] "Low density of surface defects" means that the wafer has extremely small numbers of surface defects per square centimeter of wafer surface. If a surface defect exists, electricity flows through that surface defect, and the chip cannot be used as power device. On the other hand, SiC power device for large current requires large SiC chip. Therefore, low density of surface defects is necessary for achievement of high yields in production of power devices. SDK's second generation high-grade SiC epi-wafer (HGE-2G), which is to be supplied for Toshiba, has achieved 1/2 or less density of surface defects compared to that of the first generation product (HGE).About Showa Denko K.K.Showa Denko K.K. (SDK; TSE:4004, ADR:SHWDY) is a major manufacturer of chemical products serving from heavy industry to computers and electronics. The Petrochemicals Sector provides cracker products such as ethylene and propylene, the Chemicals Sector provides industrial, high-performance and high-purity gases and chemicals for semicon and other industries, the Inorganics Sector provides ceramic products, such as alumina, abrasives, refractory/graphite electrodes and fine carbon products. The Aluminum Sector provides aluminum materials and high-value-added fabricated aluminum, the Electronics Sector provides HD media, compound semiconductors such as ultra high bright LEDs, and rare earth magnetic alloys, and the Advanced Battery Materials Department (ABM) provides lithium-ion battery components. For more information, visit www.sdk.co.jp/english/.Media contact:Showa Denko K.K., CSR & Corporate Communication Office, Tel: 81-3-5470-3235 Copyright 2021 JCN Newswire. All rights reserved. (via SEAPRWire)
TOKYO, Sep 21, 2021 - (ACN Newswire via SEAPRWire.com) - Olympus Corporation (Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced the launch of the first devices in the new POWERSEAL(TM) family of advanced bipolar surgical energy products. The POWERSEAL 5mm Curved Jaw Tissue Sealer and Divider, Double-Action devices meet the highest standards of clinical performance for advanced bipolar surgical energy devices by delivering consistent sealing reliability in an ergonomic, multifunctional design that promotes procedural efficiency.[i]The POWERSEAL 5mm Curved Jaw Tissue Sealer and Divider, Double-ActionWith the release of the POWERSEAL devices, Olympus is introducing a line of versatile advanced bipolar surgical energy devices that augment an extensive and differentiated surgical energy portfolio, which features the unique THUNDERBEAT(TM) hybrid energy devices and SONICBEAT(TM) ultrasonic dissectors. The POWERSEAL devices position Olympus competitively within the growing global market for advanced bipolar surgical energy devices, currently estimated at over $1.2B USD.[ii]The POWERSEAL devices provide surgeons with state-of-the-art sealing, dissection, and grasping capabilities in laparoscopic or open surgery while greatly reducing the force required by the surgeon to close the jaws.[iii] The POWERSEAL devices can be used in numerous forms of surgical intervention including general surgery and gynecological, colorectal, bariatric, urological, thoracic, and vascular surgical procedures.The POWERSEAL devices are single-use devices designed to optimize patient outcomes, with features including:- Strong and efficient sealing of vessels up to and including 7mm in less than 3 seconds, on average, with proven vessel burst pressure reliability of 3x systolic blood pressure (>99% confidence)[i]- Reduced reach distances to device landmarks (jaw lever, cut trigger, shaft rotation wheel), when compared to the predicate device, and reduced squeeze force requirements for the jaw lever, which may reduce hand strain and make the devices easier to use, particularly for those with smaller hands[iii]- Multifunctional capabilities such as dissection via the curved and tapered, double-action jaw, which are designed to reduce instrument exchanges during surgery- Minimal thermal spread with fast cool-down times and low exterior jaw temperatures, which can reduce risk of damage to adjacent tissue and structures[iv]"Initial clinical experience has shown that the new 5mm POWERSEAL devices offer uniform tissue compression for consistently strong sealing," said Justin A. Maykel, MD, Chief of Colon and Rectal Surgery at UMass Memorial Health. "The product design makes the devices both intuitive and safe to use.""We are thrilled to expand our surgical energy product portfolio with best-in-class advanced bipolar energy solutions that were designed with surgeons' needs and clinical outcomes as the primary drivers," said Phil Roy, Global Vice President and General Manager for Surgical Devices in the Therapeutic Solutions Division of Olympus Corporation. "These POWERSEAL devices were developed with a core requirement of zero compromise in meeting our goals of strength, efficiency and physician comfort. Testing showed we exceeded our goals across the key measures of surgical energy device performance such as sealing speed, reliability and thermal profile, all while delivering a superior user experience."[v]The Olympus Energy platform, made up of the ESG-400(TM) and USG-400(TM) electrosurgical generators, offers hospitals a complete energy solution for any operating room and powers the full range of Olympus Energy systems: monopolar, bipolar (HiQ (TM), HICURA (TM), PK (TM) and Everest (TM) devices), ultrasonic (SONICBEAT devices), hybrid energy (THUNDERBEAT devices) and advanced bipolar (POWERSEAL devices). By operating from one energy platform, hospitals can reduce capital expenditures while meeting the other goals of the Quadruple aim,[vi] availing themselves of a range of surgical energy technologies that have been designed with both the patient and the physician in mind.Advanced bipolar energy devices are distinguished from traditional bipolar energy devices through more efficient energy delivery, intuitive tissue monitoring, and uniform pressure applied to the tissue by the device jaws. These attributes enable Advanced Bipolar technologies to deliver more consistent and larger (7mm) vessel sealing than standard bipolar technology counterparts.[i]The POWERSEAL devices are regulatory approved for sale in the U.S., Puerto Rico and Australia at this time, and are actively under review in numerous other global markets.For more information about POWERSEAL, including usage and risks associated with use, visit medical.olympusamerica.com/products/powerseal or refer to the Instructions for Use.The POWERSEAL devices are best-in-class advanced bipolar energy solutions providing consistent and strong tissue sealing, as well as dissection and grasping capabilities. With an ergonomic design, the POWERSEAL devices reduce the force needed to close the jaws and reduce the reach distances to the jaw lever, cut trigger, and shaft rotation wheel. The POWERSEAL devices can be used in laparoscopic or open surgery, including general surgery and gynecological, colorectal, bariatric, urological, thoracic, and vascular surgical procedures.[i] Internal test report DN0043135[ii] Global Market Forecast, Advanced Energy, 2021 - 2025. 2020 DRG Global Market Model; latest MedTech 360 Laparoscopic and Open Market Reports: US, EU, Asia Pac & Japan[iii] Internal test report DN0046457[iv] Based on internal tissue testing with Histology reports - DN0044287, DN0044290[v] Based on GLP Acute & Chronic animal studies reports - DN0044705, DN0044706[vi] Bodenheimer T, Sinsky C. From triple to quadruple aim: care of the patient requires care of the provider. Ann Fam Med. 2014;12(6):573-576. doi:10.1370/afm.1713About OlympusAs a leading medical technology company, Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of EndoTherapy devices. For more information, visit www.medical.olympusamerica.com. Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)
TOKYO, Sept 21, 2021 - (ACN Newswire via SEAPRWire.com) - Olympus Corporation (Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced the launch of the first devices in the new POWERSEAL™ family of advanced bipolar surgical energy products. The POWERSEAL 5mm Curved Jaw Tissue Sealer and Divider, Double-Action devices meet the highest standards of clinical performance for advanced bipolar surgical energy devices by delivering consistent sealing reliability in an ergonomic, multifunctional design that promotes procedural efficiency.[i]With the release of the POWERSEAL devices, Olympus is introducing a line of versatile advanced bipolar surgical energy devices that augment an extensive and differentiated surgical energy portfolio, which features the unique THUNDERBEAT™ hybrid energy devices and SONICBEAT™ ultrasonic dissectors. The POWERSEAL devices position Olympus competitively within the growing global market for advanced bipolar surgical energy devices, currently estimated at over $1.2B USD.[ii]The POWERSEAL devices provide surgeons with state-of-the-art sealing, dissection, and grasping capabilities in laparoscopic or open surgery while greatly reducing the force required by the surgeon to close the jaws.[iii] The POWERSEAL devices can be used in numerous forms of surgical intervention including general surgery and gynecological, colorectal, bariatric, urological, thoracic, and vascular surgical procedures.The POWERSEAL 5mm Curved Jaw Tissue Sealer and Divider, Double-ActionThe POWERSEAL devices are single-use devices designed to optimize patient outcomes, with features including: Strong and efficient sealing of vessels up to and including 7mm in less than 3 seconds, on average, with proven vessel burst pressure reliability of 3x systolic blood pressure (>99% confidence)i Reduced reach distances to device landmarks (jaw lever, cut trigger, shaft rotation wheel), when compared to the predicate device, and reduced squeeze force requirements for the jaw lever, which may reduce hand strain and make the devices easier to use, particularly for those with smaller handsiii Multifunctional capabilities such as dissection via the curved and tapered, double-action jaw, which are designed to reduce instrument exchanges during surgery Minimal thermal spread with fast cool-down times and low exterior jaw temperatures, which can reduce risk of damage to adjacent tissue and structures[iv]"Initial clinical experience has shown that the new 5mm POWERSEAL devices offer uniform tissue compression for consistently strong sealing," said Justin A. Maykel, MD, Chief of Colon and Rectal Surgery at UMass Memorial Health. "The product design makes the devices both intuitive and safe to use.""We are thrilled to expand our surgical energy product portfolio with best-in-class advanced bipolar energy solutions that were designed with surgeons' needs and clinical outcomes as the primary drivers," said Phil Roy, Global Vice President and General Manager for Surgical Devices in the Therapeutic Solutions Division of Olympus Corporation. "These POWERSEAL devices were developed with a core requirement of zero compromise in meeting our goals of strength, efficiency and physician comfort. Testing showed we exceeded our goals across the key measures of surgical energy device performance such as sealing speed, reliability and thermal profile, all while delivering a superior user experience."[v]The Olympus Energy platform, made up of the ESG-400™ and USG-400™ electrosurgical generators, offers hospitals a complete energy solution for any operating room and powers the full range of Olympus Energy systems: monopolar, bipolar (HiQ ™, HICURA ™, PK ™ and Everest ™ devices), ultrasonic (SONICBEAT devices), hybrid energy (THUNDERBEAT devices) and advanced bipolar (POWERSEAL devices). By operating from one energy platform, hospitals can reduce capital expenditures while meeting the other goals of the Quadruple aim,[vi] availing themselves of a range of surgical energy technologies that have been designed with both the patient and the physician in mind.Advanced bipolar energy devices are distinguished from traditional bipolar energy devices through more efficient energy delivery, intuitive tissue monitoring, and uniform pressure applied to the tissue by the device jaws. These attributes enable Advanced Bipolar technologies to deliver more consistent and larger (7mm) vessel sealing than standard bipolar technology counterparts.iThe POWERSEAL devices are regulatory approved for sale in the U.S., Puerto Rico and Australia at this time, and are actively under review in numerous other global markets.For more information about POWERSEAL, including usage and risks associated with use, visit medical.olympusamerica.com/products/powerseal or refer to the Instructions for Use. The POWERSEAL devices are best-in-class advanced bipolar energy solutions providing consistent and strong tissue sealing, as well as dissection and grasping capabilities. With an ergonomic design, the POWERSEAL devices reduce the force needed to close the jaws and reduce the reach distances to the jaw lever, cut trigger, and shaft rotation wheel. The POWERSEAL devices can be used in laparoscopic or open surgery, including general surgery and gynecological, colorectal, bariatric, urological, thoracic, and vascular surgical procedures.[i] Internal test report DN0043135[ii] Global Market Forecast, Advanced Energy, 2021 – 2025. 2020 DRG Global Market Model; latest MedTech 360 Laparoscopic and Open Market Reports: US, EU, Asia Pac & Japan[iii] Internal test report DN0046457[iv] Based on internal tissue testing with Histology reports – DN0044287, DN0044290[v] Based on GLP Acute & Chronic animal studies reports – DN0044705, DN0044706[vi] Bodenheimer T, Sinsky C. From triple to quadruple aim: care of the patient requires care of the provider. Ann Fam Med. 2014;12(6):573-576. doi:10.1370/afm.1713About Olympus As a leading medical technology company, Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of EndoTherapy devices. For more information, visit www.medical.olympusamerica.com. Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)
SINGAPORE - At the height of e-scooters' popularity less than two years ago, retailer Mobot could sell up to a thousand of them each month. But after personal mobility devices (PMDs), including e-scooters, were banned from footpaths in November 2019, demand for the devices plunged. Now, Mobot's e-scooter sales are just 5 per cent of what they were previously. Please subscribe or log in to continue reading the full article. Get unlimited access to all stories at $0.99/month Latest headlines and exclusive stories In-depth analyses and award-winning multimedia content Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months* Subscribe now *Terms and conditions apply.
Toyota City, Japan, Apr 27, 2021 - (JCN Newswire via SEAPRWire.com) - Suzuki Motor Corporation, Subaru Corporation, Daihatsu Motor Co. Ltd., Toyota Motor Corporation, and Mazda Motor Corporation reached an agreement to jointly develop technical specifications for next-generation vehicle communications devices and to promote the common use of communications systems, by using connected services to link automobiles and society with the aim of creating new appeal, value and services, to be standardized for early provision of safer and more convenient connected services.Conceptual Diagram of Connected Service OperationWithin the field of CASE (connected, autonomous/automated, shared, and electric), which is said to be bringing about major transformations in the automotive industry, rapid advances are being made in the connected domain, in relation to the communications and data aspects of technology and business including cloud services, IoT, big data, and AI. Individual automobile manufacturers are independently developing vehicle communications devices, and even in cases where the same connected services such as remote operation functions are provided, each company is adopting a different approach in proceeding with development and deploying relevant resources.In response to these circumstances, the companies can provide safer and more convenient connected services to customers as early as possible, by positioning the development of vehicle communications devices, which are basic functions of the connected car, as a cooperative domain; positioning the development of applications and services as an in-house domain; and achieving greater efficiency and accelerating the development of vehicle communications devices. Each company can focus more on the development of applications and services on this common infrastructure through these steps.At this time, Suzuki, Subaru, Daihatsu, and Mazda, while incorporating their own technologies into the base vehicle communications technologies developed by Toyota, will together build systems for next-generation connected cars with common connection specifications from vehicles to networks and the vehicle communications device center. As a result, by stabilizing the communication quality between vehicles and vehicle communications device center further, it will be possible to provide more convenient connected services to customers, such as clearer calls between customers and operators and faster connection speeds.At the same time, it will be possible to reduce the development burdens of each participating company and simplify system operation and version upgrades that include additional new functions, thereby optimizing resources such as facilities and personnel.Suzuki, Subaru, Daihatsu, Toyota, and Mazda will openly consider collaboration with other like-minded partners regarding the joint development agreed on at this time while continuing their efforts to develop services that enrich the lives of people and solve social problems. Copyright 2021 JCN Newswire. All rights reserved. (via SEAPRWire)
Fujitsu Fuels Big Data Innovation in Mobility Space with Launch of “Digital Twin Collector” Platform
TOKYO, Apr 15, 2021 - (JCN Newswire via SEAPRWire.com) - Fujitsu today announced the launch of a new integrated virtual platform for the mobility space, which allows users to seamlessly integrate and manage information on devices including connected cars, smartphones, and tablets. Fujitsu will offer the new platform, the "Fujitsu Future Mobility Accelerator Digital Twin Collector," to automobile manufacturers and insurance companies in the Japanese market from April 22, with availability to follow in North America and Europe from June 2021, contributing to the realization of new mobility services on a global scale.As a wide-area distributed data access technology optimized for mobility, the Digital Twin Collector delivers stable communications by regulating the volume of data sent from the mobility device to the cloud with the Traffic Scheduler Function, while the Data Coverage Control Function enables comprehensive data collection without duplication. These functions make it possible to reproduce and process large volumes of data from mobility devices on the cloud platform as needed, significantly reducing costs for the management and transmission of large amounts of vehicle and traffic data.With the development of this platform, Fujitsu demonstrates its ongoing contributions to the realization of automated driving systems, including the creation of high-precision maps used by automobile manufacturers, etc., as well as offering detailed data on driving conditions including congestion, obstacles, and weather to vehicles on the road by road management companies.BackgroundIn recent years, the world has faced growing demand for innovative solutions to the challenges posed by exponential increases in data generated by connected vehicles and the digital transformation of transportation through new mobility technologies. To address this, Fujitsu has developed and launched its stream data processing platform, "Digital Twin Utilizer," as well as an in-vehicle camera image analysis platform, "Digital Twin Analyzer."The introduction of Fujitsu's new "Digital Twin Collector", which greatly reduces the cost of data collection and storage by virtually integrating and managing the data held by mobility devices, represents the latest development in this ongoing effort to streamline the use of big data with digital twin technology.Digital Twin Collector Overview1. Distributed management of data held by mobility devices reduces data collection and storage costsThe platform virtually integrates distributed data by managing only lightweight metadata (1), rather than storing large amounts of data such as video recorded by mobility devices in the cloud. This allows users, including car manufacturers and insurance companies, to access only the data they need, significantly reducing the amount of data and traffic in the cloud, delivering cost savings of 50% (2).2. Traffic Scheduler Function provides stable data access by regulating congestion of large-volume data communications.When it is necessary to collect video data simultaneously from one's own vehicle and surrounding vehicles due to an accident, etc., the burden on the cloud side increases rapidly and congestion occurs as data is accessed and copied from each device. This may disrupt the flow of data or reduce data accessibility. The new Traffic Scheduler Function regulates bulk traffic by controlling data replication requests from mobility devices. This provides stable data access.3. Data Coverage Control Function delivers consistent service quality by keeping data duplication under control and performing comprehensive replicationBiases introduced at the time training data is collected for self-driving systems may impact service quality. The Data Coverage Control function performs a cross-sectional analysis of the data access and acquisition status for a large number of mobility devices, thereby contributing both to the prevention of duplication of similar data, such as video data with the same time, location, and viewing angle, and the completeness of the acquired data. This helps to ensure service quality for the data being used for analysis as well as the service itself.Use Case- Improving the efficiency and sophistication of insurance operations When an accident is detected, simply by specifying the location and time of the accident, a video from before and after the accident can be automatically obtained for the vehicle and surrounding vehicles. This allows insurance companies to provide automotive insurance service that handles accidents in a way that takes into account multiple perspectives.- Upgrading road management services Based on vehicle behavior, the system can capture images in real time related to traffic congestion, accidents, falling obstacles, bad weather, and other events occurring on the road, enabling the road management company to provide detailed traffic control services in a timely manner.- Vehicle failure analysis By collecting peripheral images when abnormal values are detected by vehicle sensors, automobile manufacturers can use them to estimate the cause of failure and provide feedback for vehicle development.Service OverviewIn addition to the basic service that virtually integrates and manages data distributed on mobility devices, Fujitsu will offer several types of services, including a requirement definition support service that organizes requirements according to customer needs, setup service that creates usage environments, support service and customization service at individual quotation basis.(1) Metadata:Additional information related to the data, including basic information such as who created the data, where it was created, when it was created, how to access the data, and information describing the contents of the data.(2) delivering cost savings of 50%:Comparison with the case where all data is aggregated and accumulated on a cloud platform.About FujitsuFujitsu is the leading Japanese information and communication technology (ICT) company offering a full range of technology products, solutions and services. Approximately 130,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.9 trillion yen (US$35 billion) for the fiscal year ended March 31, 2020. For more information, please see www.fujitsu.com. Copyright 2021 JCN Newswire. All rights reserved. (via SEAPRWire)
TOKYO, JP & CENTER VALLEY, PA, Dec 6, 2020 - (ACN Newswire) - Olympus Corporation (TSE: 7733) today announced that it has entered into an agreement to acquire Veran Medical Technologies, Inc. (VMT) (CEO: Jason Pesterfield), a leading provider of advanced medical devices specializing in interventional pulmonology, for up to USD 340 million. The acquisition will be implemented through Olympus subsidiary Olympus Corporation of the Americas (OCA), and will be the latest in a series of strategic acquisitions designed to strengthen Olympus' position as a leading global medical device company.As part of Olympus' Corporate Strategy, unveiled in November 2019, the company vowed to "focus and scale" its therapeutic solutions division. To accelerate the process and provide greater agility, Olympus made OCA the company's therapeutic division headquarters, recognizing the significant growth opportunities in North America. The company also identified three core medical fields to prioritize - gastroenterological endotherapy devices, urological devices, and respiratory devices. The VMT acquisition is centered on respiratory devices and will position Olympus as a leader in this field.According to Nacho Abia, global chief operating officer and CEO of OCA, the VMT acquisition will strategically position Olympus and boost development in other areas, "We are very excited about acquiring VMT because its portfolio of devices will complement our product portfolio and further strengthen our position in respiratory medical devices," he said. "The most significant part of this deal is that we will secure immediate access to VMT's unique Electromagnetic Navigation system with proprietary devices to build a stronger future respiratory product portfolio."Already a leader in bronchoscopy systems, Olympus' endoscope technologies will combine perfectly with VMT's navigation products to develop solutions for improved diagnosis of peripheral lung cancer.Lung cancer affects the highest number of cancer patients and is the leading cause of cancer-related deaths globally.* With increased awareness and more lung cancer screenings done by low-dose CT (computed tomography), the need for definitive diagnosis of lesions in the peripheral regions of the lungs by tissue biopsy is expected to increase. Combined with Olympus' technology, VMT's navigational platform and proprietary devices support this need."We are proud to be joining forces with Olympus, a company with a 100-year legacy and a global reputation for quality, leadership and innovation," said Jason Pesterfield, CEO of VMT. "Olympus has a clear strategy to become a global medtech leader, and we're excited to contribute our unique capabilities and become part of this journey."This acquisition will provide immediate incremental revenue and an experienced sales team within the US market. VMT's advanced and proven navigation technology, together with Olympus' respiratory leadership, strengthens and enhances Olympus' global position. For details, please refer to our corporate disclosure, "Notice regarding acquisition of Veran Medical Technologies, Inc. in the United States." (Available at: https://www.olympus-global.com/news/ir/2020/)* WHO data: https://www.who.int/news-room/fact-sheets/detail/cancerAbout Veran Medical Technologies, Inc.VMT is a privately held medical device company headquartered in St. Louis, MO. The company's mission is to empower physicians to diagnose cancer earlier and to enable precision therapy to save lives. In the United States, lung cancer kills more people each year than breast, prostate, and colon cancers combined.VMT has developed and commercialized a next-generation electromagnetic thoracic navigation platform called the SPiN Thoracic Navigation System(R). This breakthrough technology has been adopted by leading cancer centers throughout the United States. VMT also provides physicians with a full line of bronchoscopic brushes, needles, forceps and steerable catheters with tiny electromagnetic sensors embedded in the tips for precise navigation. The combination of these proprietary Always-On Tip Tracked(R) instruments and VMT's exclusive patient respiratory gating technology enables physicians to accurately access lung nodules by accounting for nodule movement during patient breathing, a common challenge for lung specialists. The SPiN Thoracic Navigation System(R) is the first and only technology that enables Pulmonologists or Thoracic Surgeons to accurately access lung nodules outside of an airway using SPiN Perc(R), a navigated transthoracic needle. With SPiN Perc(R), VMT combines endobronchial navigation with percutaneous navigation, allowing physicians to access all lung nodules in a single procedure, regardless of nodule size or location. This eliminates the cost and risk of unnecessary procedures and empowers physicians to provide a same day diagnosis for their patients. Please visit www.veranmedical.com.About Olympus' Therapeutic Solutions businessIn its Therapeutic Solutions business, Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Starting with its early contributions to the development of the polypectomy snare, Olympus' Therapeutic Solutions portfolio has grown to include an array of surgical energy devices and a wide range of instruments to help prevent, detect, and treat disease. For more information, visit www.olympus-global.com. Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com
TOKYO, JP & CENTER VALLEY, PA, Dec 4, 2020 - (JCN Newswire) - Olympus Corporation (TSE: 7733) today announced that it has entered into an agreement to acquire Veran Medical Technologies, Inc. ("VMT")(CEO: Jason Pesterfield), a leading provider of advanced medical devices specializing in interventional pulmonology, for up to USD 340 million. The acquisition will be implemented through Olympus subsidiary Olympus Corporation of the Americas ("OCA"), and will be the latest in a series of strategic acquisitions designed to strengthen Olympus' position as a leading global medical device company.As part of Olympus' Corporate Strategy, unveiled in November 2019, the company vowed to "focus and scale" its therapeutic solutions division. To accelerate the process and provide greater agility, Olympus made OCA the company's therapeutic division headquarters, recognizing the significant growth opportunities in North America. The company also identified three core medical fields to prioritize - gastroenterological endotherapy devices, urological devices, and respiratory devices. The VMT acquisition is centered on respiratory devices and will position Olympus as a leader in this field.According to Nacho Abia, global chief operating officer and CEO of OCA, the VMT acquisition will strategically position Olympus and boost development in other areas, "We are very excited about acquiring VMT because its portfolio of devices will complement our product portfolio and further strengthen our position in respiratory medical devices," he said. "The most significant part of this deal is that we will secure immediate access to VMT's unique Electromagnetic Navigation system with proprietary devices to build a stronger future respiratory product portfolio."Already a leader in bronchoscopy systems, Olympus' endoscope technologies will combine perfectly with VMT's navigation products to develop solutions for improved diagnosis of peripheral lung cancer.Lung cancer affects the highest number of cancer patients and is the leading cause of cancer-related deaths globally.(*) With increased awareness and more lung cancer screenings done by low-dose CT (computed tomography), the need for definitive diagnosis of lesions in the peripheral regions of the lungs by tissue biopsy is expected to increase. Combined with Olympus' technology, VMT's navigational platform and proprietary devices support this need."We are proud to be joining forces with Olympus, a company with a 100-year legacy and a global reputation for quality, leadership and innovation," said Jason Pesterfield, CEO of VMT. "Olympus has a clear strategy to become a global medtech leader, and we're excited to contribute our unique capabilities and become part of this journey."This acquisition will provide immediate incremental revenue and an experienced sales team within the US market. VMT's advanced and proven navigation technology, together with Olympus' respiratory leadership, strengthens and enhances Olympus' global position. For details, please refer to our corporate disclosure, "Notice regarding acquisition of Veran Medical Technologies, Inc. in the United States." (available at: https://www.olympus-global.com/news/ir/2020/)* WHO data: https://www.who.int/news-room/fact-sheets/detail/cancerAbout Veran Medical Technologies, Inc.VMT is a privately held medical device company headquartered in St. Louis, MO. The company's mission is to empower physicians to diagnose cancer earlier and to enable precision therapy to save lives. In the United States, lung cancer kills more people each year than breast, prostate, and colon cancers combined.VMT has developed and commercialized a next-generation electromagnetic thoracic navigation platform called the SPiN Thoracic Navigation System(R). This breakthrough technology has been adopted by leading cancer centers throughout the United States. VMT also provides physicians with a full line of bronchoscopic brushes, needles, forceps and steerable catheters with tiny electromagnetic sensors embedded in the tips for precise navigation. The combination of these proprietary Always-On Tip Tracked(R) instruments and VMT's exclusive patient respiratory gating technology enables physicians to accurately access lung nodules by accounting for nodule movement during patient breathing, a common challenge for lung specialists. The SPiN Thoracic Navigation System(R) is the first and only technology that enables Pulmonologists or Thoracic Surgeons to accurately access lung nodules outside of an airway using SPiN Perc(R), a navigated transthoracic needle. With SPiN Perc(R), VMT combines endobronchial navigation with percutaneous navigation, allowing physicians to access all lung nodules in a single procedure, regardless of nodule size or location. This eliminates the cost and risk of unnecessary procedures and empowers physicians to provide a same day diagnosis for their patients. About Olympus' Therapeutic Solutions businessIn its Therapeutic Solutions business, Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Starting with its early contributions to the development of the polypectomy snare, Olympus' Therapeutic Solutions portfolio has grown to include an array of surgical energy devices and a wide range of instruments to help prevent, detect, and treat disease. For more information, visit www.olympus-global.com. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com













